Grab is in M&A discussions with GoTo Group in Southeast Asia, while Eli Lilly markets pharmaceuticals in the US.
1 report, 1 independent
Updated Jul 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Grab is in M&A discussions with GoTo Group in Southeast Asia, while Eli Lilly markets pharmaceuticals in the US.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Grab
Southeast Asian technology company headquartered in Singapore
-
GoTo
Israeli company
-
Eli Lilly and Company
American pharmaceutical company
Related events
- Grab, a Singapore-based multinational technology company, operates a superapp across Southeast Asia.
- Grab competes with Maxim Integrated in Thailand, operating across key locations including Chiang Rai, Chiang Mai, and Bangkok.
- Grab announced plans to buy a stake in Atome, while drivers protested pay and macro pressures affected growth stocks.
- Grab operates in Jakarta, Kuala Lumpur, and Singapore.
Coverage
Newest first; wire copies grouped- Simply Wall St.3 Stocks Including Grab Holdings That May Be Undervalued For Your Portfolio Over the last 7 days, the United States market has remained flat, yet it has experienced a notable 12% rise over the past y